Thomas Hutson - Baylor Health Care System

基本信息

Career Trajectory

Bio

GU/Uroloigc Medical Oncologist engaged in clinical research to improve outcomes for patients with Kidney Cancer, Bladder Cancer, Prostate Cancer and Testicular Cancer.

Research Interests

Papers共 387 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Updated Overall Survival in Patients with Prior Checkpoint Inhibitor Therapy in the Phase III TIVO-3 Study

Miguel Zugman,David F. Mcdermott,Bernard J. Escudier,Thomas E. Hutson,Camillo Porta,Elena Verzoni,Michael B. Atkins,Brian Rini,Sumanta K. Pal

ONCOLOGISTno. 2 (2025)

Cited0Views0WOSBibtex

Biomarker Analyses from the Phase 3 Randomized CLEAR Trial: Lenvatinib Plus Pembrolizumab Versus Sunitinib in Advanced Renal Cell Carcinoma

R.J. Motzer,C. Porta,M. Eto,T.E. Hutson,S.Y. Rha,J.R. Merchan,E. Winquist,H. Gurney,V. Grünwald,S. George, J. Markensohn,J.E. Burgents,R. Cristescu,P. Sachdev, Y. Narita, J. Huang, Z. Zhao,C.E. Okpara,Y. Minoshima,T.K. Choueiri

Annals of Oncology (2024)

Cited0Views0WOSBibtex

5 A Phase 1b, Open-Label, Safety, Tolerability, and Efficacy Study of HC-7366 in Combination with Belzutifan (WELIREGTM) in Patients with Advanced or Metastatic Renal Cell Carcinoma, NCT06234605

Rana R McKay, Ben Garmezy,Pedro Barata,Moshe Ornstein,Neil J Shah,Hans Hammers,Thomas E Hutson,Michael Chisamore, Dhamina Karim,Paulette Mattson,Eric Lightcap,Jeremy Drees,Ben Harrison, Megan Holm,Nandita Bose, Cherry T Thomas,Robert J Motzer

The Oncologistno. Supplement_1 (2024)

Cited0Views0Bibtex

Avelumab First-Line Maintenance for Locally Advanced or Metastatic Urothelial Carcinoma: Results from the Real-World US PATRIOT-II Study

Petros Grivas,Pedro Barata,Helen Moon,Shilpa Gupta,Thomas Hutson,Cora N. Sternberg,Jason R. Brown,Vaidehi Dave,Chad Downey,Alicia C. Shillington,Howard M. Katzenstein,Melissa Kirker, Sarah Hanson,Frank X. Liu, Valerie Morris,Abhijeet Bhanegaonkar,Guru P. Sonpavde

Clinical Genitourinary Cancerno. 6 (2024): 102238

Cited0Views0Bibtex

Estimated Cost of VEGFR TKI Associated Adverse Events in Metastatic Renal Cell Carcinoma Patients

Jeffrey Thomas Yorio,Aviva G. Asnis-Alibozek,Vijay Kasturi,Thomas E. Hutson

BMC Health Services Researchno. 1 (2024): 1-8

Cited0Views0WOSBibtex

A Phase 1/1b First-in-human (FIH) Study of JZP898 As Monotherapy and in Combination with Pembrolizumab in Adult Patients with Advanced or Metastatic Solid Tumors

Meredith McKean,Thomas E. Hutson,Sarina A. Piha-Paul,Ida Micaily, Mingxiang Liao,Robin Humphreys,Graham Brock,Natasha Sahr,Vian Amber,Alexander I. Spira

Journal of Clinical Oncologyno. 16_suppl (2024): TPS3190-TPS3190

Cited0Views0Bibtex

A Multicenter, Open-Label, Phase 1a Study of HC-5404 in Patients with Advanced Solid Tumors

Arkadiusz Z. Dudek,Joyce O'Shaughnessy,Sarina A. Piha-Paul,Dipesh Uprety, Benjamin Lee Kitchens,Thomas E. Hutson, Brian H. Rank,Michael Stokes,Crissy Dudgeon,David Surguladze,Eric Lightcap,Jeremy Drees,Ben Harrison, Richard Li,Ashley LaCayo,Paulette Mattson,Nandita Bose, Dhamina Karim,Michele Anne Gargano,Jose Luis Iglesias

Journal of Clinical Oncologyno. 16_suppl (2024): e15118-e15118

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn